Growth through acquisitions D2 Solutions recently acquired ProModRx, signaling a strategic expansion and integration of cloud-based patient access capabilities. This presents opportunities to cross-sell UltraTouch Verify and related access solutions to a larger installed base and to align with ProModRx customers seeking faster prescription fulfillment.

Strategic partnerships A collaboration with Elevate Health Technologies to embed UltraTouch Verify within OnePulse Connect indicates a market push for integrated prior authorization technology and streamlined patient access. This creates a pathway to pursue similar platform integrations with health systems, pharmacies, and payers seeking seamless workflows.

SaaS and consulting D2 Solutions combines software as a service with consulting expertise to reduce friction between product and patient. This dual offering positions an opportunity to pitch combined licenses and advisory services to hospital systems, pharmacies, hubs, and manufacturers aiming to improve efficiency, risk management, and patient access.

Funding and growth Recent growth funding from Decathlon Capital Partners signals capital readiness for scale. This may open doors for expand-and-deploy strategies, larger pilot programs, and joint go-to-market efforts with strategic investors targeting healthcare technology adoption and patient access optimization.

Mid-market focus With 51-200 employees and a revenue range of 10–25 million, D2 Solutions sits in a mid-market segment that often seeks pragmatic, fast-implementing tech and services. This suggests strong potential for scalable, repeatable deployments of UltraTouch Verify and related platforms across hospital systems, pharmacies, PBMs, and payers seeking measurable ROI.